Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Withdrawn Phase 3 Interventional

Major Depressive Disorder With Mixed Features

ClinicalTrials.gov ID: NCT01423240

Public ClinicalTrials.gov record NCT01423240. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 5:34 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, 6-week, Double-blind, Placebo-controlled, Fixed-dose, Parallel Group Study of Lurasidone for the Treatment of Major Depressive Disorder With Mixed Features

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Lurasidone HCl is a compound that is a candidate for the treatment of major depressive with mixed features.This clinical study is designed to test how well Lurasidone works to treat major depressive disorder with mixed features.

Study identification

NCT ID
NCT01423240
Recruitment status
Withdrawn
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
Not listed

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 31, 2011
Primary completion
Nov 30, 2012
Completion
Nov 30, 2012
Last update posted
Dec 12, 2012

2012

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
Birmingham Research Group Birmingham Alabama 35216
Sun Valley Behavioral Medical Imperial California 92251
Synergy Clinical Research Center National City California 91950
Excell Research Oceanside California 92056
Pacific Clinical Research Medical Group Orange California 92868
SMRI Sherman Oaks California 91403
Sarkis Clinical Trials Gainesville Florida 32607
Florida Research Center Maitland Florida 32751
University of Miami, Miller School Miami Florida 33136
Miami Research Miami Florida 33143
Atlanta Center for Medical Research Atlanta Georgia 30308
Comprehensive NeuroScience Inc. Atlanta Georgia 30328
Hawaii Clinical Research Center Honolulu Hawaii 86813
Psychiatric Medicine Associates Skokie Illinois 60076
Goldpoint Clinical Research Indianapolis Indiana 46260
CRI Worldwide Willingboro New Jersey 08054
Medical & Behavioral Health Research New York New York 10023
Montefiore Medical Center; Anxiety & Depression Clinic; Dept. of Psychiatry The Bronx New York 10467
New Hope Clinical Research Hickory North Carolina 28601
Sooner Clinical Research Oklahoma City Oklahoma 73112
Lehigh Center for Clinical Research Allentown Pennsylvania 18104
Suburban Research Associates Media Pennsylvania 19063
Harry Croft and Associates San Antonio Texas 78229
University of Texas Health Science Center San Antonio Texas 78229
Grayline Clinical Drug Trials Wichita Falls Texas 76309
Department of Psychiatry, University of Utah Health Sciences Center Salt Lake City Utah 84132
Northwest Clinical Research Center Bellevue Washington 98007

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01423240, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 12, 2012 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01423240 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →